Primer: Checkpoint Therapeutics (CKPT US) - Aug 2026
Checkpoint Therapeutics is a clinical-stage biopharmaceutical company on the cusp of commercialization, with its lead drug, cosibelimab...
103 Views
𝛼SK or SearchENTITY
Checkpoint Therapeutics (CKPT US)
Checkpoint Therapeutics (CKPT US)
12
Analysis
Health Care • United States
Checkpoint Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on the acquisition, development, and commercialization of immune-enhanced combination treatments for patients with solid tumor cancers. Checkpoint Therapeutics serves patients in the United States.
morex